In last week’s post, we reviewed Pluymaekers et al (1), a randomized control trial from the Netherlands on early or delayed cardioversion for recent-onset atrial fibrillation (AF). In this post, we will analyze our practice in the U.S. and discuss some of the arguments for and against cardioversion in the Read more…
A recent NEJM article, “Early or Delayed Cardioversion in Recent-Onset Atrial Fibrillation” by Pluymaekers et al has reinvigorated debate in the blogosphere, academia conference halls, and podcast-dom over management of recent-onset atrial fibrillation (AF) (1,2,3). Prior studies have demonstrated that cardioversion for recent-onset atrial fibrillation (typically defined by a duration Read more…
Post a comment or answer one of the questions below and not only help your peers, but get asynchronous credit! OK, here’s the case! 78 year-old woman with atrial fibrillation presents with chest pain; her HR is 145, ECG shows the rhythm is irregular. Her blood pressure is 90/50. Her baseline BP is Read more…